{"id":728869,"date":"2023-02-06T08:33:52","date_gmt":"2023-02-06T13:33:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/"},"modified":"2023-02-06T08:33:52","modified_gmt":"2023-02-06T13:33:52","slug":"connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/","title":{"rendered":"Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO and TAICANG, SUZHOU, China, Feb.  06, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lKz9NTL1eUZNfxzUDDMtc4KH0u9Vo0IFQMamaMIFuVsF4UVOPG3a-HWKAxkWU2Up-xn-ldmfsVwZU3liACj_ar-p8HhxUVRCEKWb0TaGYMKXRGxb_pYZjxE0PIwfck1j\" rel=\"nofollow noopener\" target=\"_blank\">Connect Biopharma Holdings Limited<\/a> (Nasdaq: CNTB), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases, today announced it will be presenting, and hosting one-on-one meetings, at the following conferences in February and March 2023:<\/p>\n<ul type=\"disc\">\n<li>SVB Securities Global Biopharma Conference, February 15 at 4:10 pm Eastern\/1:10pm Pacific. To view the presentation live please, follow this link: <a href=\"https:\/\/wsw.com\/webcast\/svb8\/cntb\/1610037\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/svb8\/cntb\/1610037<\/a><a href=\"https:\/\/wsw.com\/webcast\/svb8\/cntb\/1610037\" rel=\"nofollow noopener\" target=\"_blank\"><br \/><\/a>A replay will be available for 90 days, until April 17.<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">BioCom Global Partnering and Investor Conference, February 28 \u2013 March 2, at the Lodge at Torrey Pines, La Jolla, Calif.<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>About Connect Biopharma Holdings Limited<\/strong>\n      <\/p>\n<p align=\"justify\">Connect Biopharma is a global, clinical-stage biopharmaceutical company applying its expertise in T cell biology and deep knowledge of the drug discovery industry to develop innovative therapies to treat chronic inflammatory diseases with the goal of improving the lives of millions of those affected around the world. The Company is building a rich pipeline of proprietary small molecules and antibodies, using functional T cell assays, to screen and discover potent product candidates against validated immune targets. The Company\u2019s lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha (IL-4R\u03b1) in development for the treatment of atopic dermatitis and asthma. The Company\u2019s second most advanced product candidate, CBP-307, is a modulator of S1P1 T cell receptor and is in development for the treatment of ulcerative colitis (UC). The Company\u2019s third product candidate, CBP-174, is a peripherally acting antagonist of histamine receptor 3, in development for the treatment of pruritus associated with AD.<\/p>\n<p align=\"justify\">For more information, please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Tj6rw7rc_stjO_X5e2glCg4Ib-CfBIZb8ETlOgo91d6h3Wu4vm1qQu-nnaBrX3IOT-UQZv6G6cO2CoOGL7Gi4098HrEmbfarETlQzjvA_vSpxOlwl4P9YlwgLR-xWVy-\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.connectbiopharm.com\/<\/a><\/p>\n<p align=\"left\">\n        <strong>INVESTOR CONTACT<\/strong>:<br \/>Ina McGuinness<br \/><strong>805.427.1372<\/strong><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PAv_EnZPeSldztZ0nfLayhpjIo9-maJEsGbA_XIdDX80HJvwqiN--Xg_X5UtFTeYnChM5lvbRZd5V9Ptg-AYzjzdT8ev4gl7jD4McAK_E0MyfkPB9TCozifEDdFUQ-D8\" rel=\"nofollow noopener\" target=\"_blank\">imcguinness@connectpharm.com<\/a><\/p>\n<p>\n        <strong>MEDIA CONTACT:<\/strong><br \/>\n        <br \/>Deanne Eagle<br \/><strong>917.837.5866<\/strong><br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LMnQgFlGLgrc552rW8U3Ul5W9gOibQHKFfkguGshBHi01Ey9ydbWdtGElUfNcircMLjG5fWmNIwPjLTxzDmlIJ1CkRbeZzIgHNRf_1inhWw=\" rel=\"nofollow noopener\" target=\"_blank\">Deanne@mcguinnessIR.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzAzNCM1MzkyMzU4IzIyMDc1MTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YTZlZTQyNmUtMmJjZC00N2JlLWJiYWItOGQ4ZjU5ZDRlY2Q3LTEyMTkwNjQ=\/tiny\/Connect-Biopharma-Holdings-Lim.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO and TAICANG, SUZHOU, China, Feb. 06, 2023 (GLOBE NEWSWIRE) &#8212; Connect Biopharma Holdings Limited (Nasdaq: CNTB), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases, today announced it will be presenting, and hosting one-on-one meetings, at the following conferences in February and March 2023: SVB Securities Global Biopharma Conference, February 15 at 4:10 pm Eastern\/1:10pm Pacific. To view the presentation live please, follow this link: https:\/\/wsw.com\/webcast\/svb8\/cntb\/1610037A replay will be available for 90 days, until April 17. BioCom Global Partnering and Investor Conference, February 28 \u2013 March 2, at the Lodge at Torrey Pines, La Jolla, Calif. About Connect Biopharma Holdings Limited Connect Biopharma is a global, clinical-stage biopharmaceutical company applying its expertise in T &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-728869","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO and TAICANG, SUZHOU, China, Feb. 06, 2023 (GLOBE NEWSWIRE) &#8212; Connect Biopharma Holdings Limited (Nasdaq: CNTB), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases, today announced it will be presenting, and hosting one-on-one meetings, at the following conferences in February and March 2023: SVB Securities Global Biopharma Conference, February 15 at 4:10 pm Eastern\/1:10pm Pacific. To view the presentation live please, follow this link: https:\/\/wsw.com\/webcast\/svb8\/cntb\/1610037A replay will be available for 90 days, until April 17. BioCom Global Partnering and Investor Conference, February 28 \u2013 March 2, at the Lodge at Torrey Pines, La Jolla, Calif. About Connect Biopharma Holdings Limited Connect Biopharma is a global, clinical-stage biopharmaceutical company applying its expertise in T &hellip; Continue reading &quot;Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-06T13:33:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzAzNCM1MzkyMzU4IzIyMDc1MTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California\",\"datePublished\":\"2023-02-06T13:33:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\\\/\"},\"wordCount\":300,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MzAzNCM1MzkyMzU4IzIyMDc1MTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\\\/\",\"name\":\"Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MzAzNCM1MzkyMzU4IzIyMDc1MTE=\",\"datePublished\":\"2023-02-06T13:33:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MzAzNCM1MzkyMzU4IzIyMDc1MTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MzAzNCM1MzkyMzU4IzIyMDc1MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/","og_locale":"en_US","og_type":"article","og_title":"Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California - Market Newsdesk","og_description":"SAN DIEGO and TAICANG, SUZHOU, China, Feb. 06, 2023 (GLOBE NEWSWIRE) &#8212; Connect Biopharma Holdings Limited (Nasdaq: CNTB), a global clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases, today announced it will be presenting, and hosting one-on-one meetings, at the following conferences in February and March 2023: SVB Securities Global Biopharma Conference, February 15 at 4:10 pm Eastern\/1:10pm Pacific. To view the presentation live please, follow this link: https:\/\/wsw.com\/webcast\/svb8\/cntb\/1610037A replay will be available for 90 days, until April 17. BioCom Global Partnering and Investor Conference, February 28 \u2013 March 2, at the Lodge at Torrey Pines, La Jolla, Calif. About Connect Biopharma Holdings Limited Connect Biopharma is a global, clinical-stage biopharmaceutical company applying its expertise in T &hellip; Continue reading \"Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-06T13:33:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzAzNCM1MzkyMzU4IzIyMDc1MTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California","datePublished":"2023-02-06T13:33:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/"},"wordCount":300,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzAzNCM1MzkyMzU4IzIyMDc1MTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/","name":"Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzAzNCM1MzkyMzU4IzIyMDc1MTE=","datePublished":"2023-02-06T13:33:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzAzNCM1MzkyMzU4IzIyMDc1MTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MzAzNCM1MzkyMzU4IzIyMDc1MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/connect-biopharma-to-present-at-svb-securities-global-biopharma-conference-and-participate-in-biocom-california\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom California"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728869","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=728869"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728869\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=728869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=728869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=728869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}